Loading clinical trials...
Loading clinical trials...
The Role of Interleukin-1 Beta Targeted Therapy for Patients Suffering From Allergic Contact Dermatitis: A Randomized Controlled Trial With Anakinra vs. Placebo
Conditions
Interventions
Anakinra
Sodium Chloride 9mg/ml Injection
Locations
1
Denmark
Gentofte Hospital
Hellerup, Denmark
Start Date
October 11, 2022
Primary Completion Date
December 1, 2023
Completion Date
August 1, 2024
Last Updated
May 20, 2025
NCT06957444
NCT03945760
NCT05858723
NCT04365140
NCT03309215
NCT03902392
Lead Sponsor
Herlev and Gentofte Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions